Related Experiment Video
Updated: May 7, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
[Impact of diabetes on clinical outcomes following multivessel percutaneous interventions]
Yan Qiao1, Shao-ping Nie, Xin Du
1Department of Cardiology, Beijing Anzhen Hospital, Capital University of Medical Sciences, Beijing 100029, China.
Insights
Diabetes significantly increases risks of mortality and stent thrombosis in patients with multivessel disease undergoing percutaneous coronary intervention (PCI). These findings highlight the critical impact of diabetes on long-term cardiovascular outcomes after PCI.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Diabetology
Context:
- Multivessel disease poses significant risks for cardiovascular events.
- Percutaneous coronary intervention (PCI) with stent implantation is a common treatment for multivessel disease.
- The impact of diabetes on long-term outcomes after PCI in this population requires further elucidation.
Purpose:
- To compare mortality, myocardial infarction (MI), repeat revascularization, and stent thrombosis rates between diabetic and nondiabetic patients with multivessel disease after PCI.
- To evaluate the long-term clinical outcome differences attributed to diabetes in patients undergoing PCI for multivessel disease.
Summary:
- A study of 1985 patients with multivessel disease found that after 24 months, diabetics had significantly higher adjusted risks of all-cause mortality (4.4% vs 2.0%) and cardiac mortality (2.7% vs 1.1%) compared to nondiabetics.
- While nonfatal MI and repeat revascularization rates were similar, diabetes was associated with a significantly increased risk of stent thrombosis.
- The overall rate of major adverse cardiac events (MACE) was higher in the diabetic group (15.8% vs 11.9%).
Impact:
- Diabetes is an independent risk factor for adverse long-term outcomes following PCI in patients with multivessel disease.
- Increased mortality, stent thrombosis, and MACE rates in diabetics underscore the need for intensified management and tailored treatment strategies.
- These findings emphasize the importance of considering diabetic status in risk stratification and treatment planning for multivessel coronary artery disease.
Objective:
To compare the rates of mortality, myocardial infarction (MI), repeat revascularization and stent thrombosis after percutaneous coronary intervention (PCI) with implantation of stents for diabetics versus nondiabetics with multivessel disease to evaluate the impact of diabetes on long-term clinical outcomes.
Methods:
We consecutively recruited a total of 1985 patients with multivessel disease at our institution from July 2003 to December 2005. And they were divided into two groups of diabetes (n = 587) or non-diabetes (n = 1398). The primary endpoint was all-cause mortality at 24 months.
Results:
After adjusting with Logistic regression, the risk of mortality in the diabetics was significantly higher than that in the nondiabetics (4.4% vs 2.0%, hazard ratio [HR] 1.83, 95% confidence interval [CI] 1.02 to 3.67, P = 0.021). Similar outcome was also found in the adjusted risk of cardiac mortality (2.7% vs 1.1%, HR = 2.04, 95%CI 1.12 to 3.89, P = 0.032) at 24 months, although the adjusted risk of nonfatal MI and repeat revascularization was similar. However, diabetes significantly increased the risk of stent thrombosis. The major adverse cardiac event (MACE) rate was also lower in the nondiabetics (15.8% vs 11.9%, HR = 1.52, 95%CI 1.12 to 1.89, P = 0.043).
Conclusion:
In patients with multivessel disease, diabetes is correlated with increase risks of mortality, stent thrombosis and MACE at long-term follow-up compared with non-diabetes.
Related Concept Videos
Complications of Diabetes Mellitus
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Foot Ulcer
Type I Diabetes III: Clinical Manifestations
Peripheral Artery Disease IV: Nursing Management

